GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » Enterprise Value

BFNH (BioForce Nanosciences Holdings) Enterprise Value : $14.07 Mil (As of Jul. 06, 2025) ***


View and export this data going back to 2004. Start your Free Trial

What is BioForce Nanosciences Holdings Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BioForce Nanosciences Holdings's Enterprise Value is $14.07 Mil. BioForce Nanosciences Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.49 Mil. Therefore, BioForce Nanosciences Holdings's EV-to-EBIT ratio for today is -28.60.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BioForce Nanosciences Holdings's Enterprise Value is $14.07 Mil. BioForce Nanosciences Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.49 Mil. Therefore, BioForce Nanosciences Holdings's EV-to-EBITDA ratio for today is -28.60.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BioForce Nanosciences Holdings's Enterprise Value is $14.07 Mil. BioForce Nanosciences Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, BioForce Nanosciences Holdings's EV-to-Revenue ratio for today is .

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, BioForce Nanosciences Holdings's Enterprise Value is $14.07 Mil. BioForce Nanosciences Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.06 Mil. Therefore, BioForce Nanosciences Holdings's EV-to-FCF ratio for today is -242.57.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


BioForce Nanosciences Holdings Enterprise Value Historical Data

The historical data trend for BioForce Nanosciences Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioForce Nanosciences Holdings Enterprise Value Chart

BioForce Nanosciences Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.08 35.12 58.25 58.84 10.00

BioForce Nanosciences Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.76 54.15 32.20 10.00 13.39

Competitive Comparison of BioForce Nanosciences Holdings's Enterprise Value

For the Packaged Foods subindustry, BioForce Nanosciences Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioForce Nanosciences Holdings's Enterprise Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BioForce Nanosciences Holdings's Enterprise Value falls into.


;
;

BioForce Nanosciences Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BioForce Nanosciences Holdings's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

BioForce Nanosciences Holdings's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioForce Nanosciences Holdings  (OTCPK:BFNH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BioForce Nanosciences Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=14.069/-0.492
=-28.60

BioForce Nanosciences Holdings's current Enterprise Value is $14.07 Mil.
BioForce Nanosciences Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BioForce Nanosciences Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=14.069/-0.492
=-28.60

BioForce Nanosciences Holdings's current Enterprise Value is $14.07 Mil.
BioForce Nanosciences Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BioForce Nanosciences Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=14.069/0
=

BioForce Nanosciences Holdings's current Enterprise Value is $14.07 Mil.
BioForce Nanosciences Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

BioForce Nanosciences Holdings's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=14.069/-0.058
=-242.57

BioForce Nanosciences Holdings's current Enterprise Value is $14.07 Mil.
BioForce Nanosciences Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioForce Nanosciences Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of BioForce Nanosciences Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BioForce Nanosciences Holdings Business Description

Traded in Other Exchanges
N/A
Address
2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.
Executives
Richard Kaiser Kaiser director, 10 percent owner, officer: Secretary/Acting CFO 3419 VIRGINIA BEACH BLVD, UNIT 252, VIRGINIA BEACH VA 23452
Merle Ferguson director, 10 percent owner, officer: CEO/President/Treasurer 2020 GENERAL BOOTH BLVD., SUITE 230, VIRGINIA BEACH VA 23454
Susan Donohue 10 percent owner 19001 S. RICHFIELD AVE, #102, GREEN VALLEY AZ 85614
Michael D Dunham director 12000 W PARK PL, EFFECTIVE MANAGEMENT SYSTEMS INC, MILWAUKEE WI 53224
Gregory D Brown officer: Chief Financial Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010-8098
Kerry M Frey officer: Chief Operating Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010
Eric Henderson director, 10 percent owner BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Lawrence Marshall Gold director 830 MENLO AVENUE, SUITE 100, MENLO PARK CA 94025
Jean-jacques Sunier director BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Societe Generale Asset Management Alternative Investments 10 percent owner 170, PLACE HENRI REGNAULT, LADEFENSE, PARIS I0 92043
Ed Cowle 10 percent owner 6 EAST 45TH ST., SUITE 1000, NEW YORK NY 10017
H Deworth Williams 10 percent owner 2681 EAST PARLEYS WAY, SUITE #204, SALT LAKE CITY UT 84109
Carter Robert P Iii 10 percent owner 25 RADCLIFFE DRIVE, VOORHEES NJ 08043
Harvey N Kaye 10 percent owner 190 NW SPANISH RIVER BLVD., SUITE 101, BOCA RATON FL 33431

BioForce Nanosciences Holdings Headlines